| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus
|
Im, Stanley W.K.
|
|
2001
|
19 |
27 |
p. 3726-3732
7 p.
|
artikel
|
| 2 |
Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles
|
Palker, Thomas J
|
|
2001
|
19 |
27 |
p. 3733-3743
11 p.
|
artikel
|
| 3 |
Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg
|
Heijtink, R.A
|
|
2001
|
19 |
27 |
p. 3671-3680
10 p.
|
artikel
|
| 4 |
A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions
|
Nodelijk, G
|
|
2001
|
19 |
27 |
p. 3636-3644
9 p.
|
artikel
|
| 5 |
Construction of a live-attenuated bivalent vaccine virus against human parainfluenza virus (PIV) types 1 and 2 using a recombinant PIV3 backbone
|
Tao, Tao
|
|
2001
|
19 |
27 |
p. 3620-3631
12 p.
|
artikel
|
| 6 |
Contrasting Epstein–Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design
|
Bharadwaj, M
|
|
2001
|
19 |
27 |
p. 3769-3777
9 p.
|
artikel
|
| 7 |
Cost of immunization with a locally produced, oral cholera vaccine in Viet Nam
|
Naficy, Abdollah B.
|
|
2001
|
19 |
27 |
p. 3720-3725
6 p.
|
artikel
|
| 8 |
Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function
|
Ishioka, Glenn Y
|
|
2001
|
19 |
27 |
p. 3710-3719
10 p.
|
artikel
|
| 9 |
Development of Th1-mediated CD8+ effector T cells by vaccination with epitope peptides encapsulated in pH-sensitive liposomes
|
Chang, Jin-Soo
|
|
2001
|
19 |
27 |
p. 3608-3614
7 p.
|
artikel
|
| 10 |
Erratum to “Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant”
|
Isaka, Masanori
|
|
2001
|
19 |
27 |
p. 3797-
1 p.
|
artikel
|
| 11 |
Erratum to “Potential live vaccines for HIV”
|
Burnett, Mary Susan
|
|
2001
|
19 |
27 |
p. 3796-
1 p.
|
artikel
|
| 12 |
Granzyme B: a marker of risk for influenza in institutionalized older adults
|
McElhaney, Janet E
|
|
2001
|
19 |
27 |
p. 3744-3751
8 p.
|
artikel
|
| 13 |
Hepatitis A control in a refugee camp by active immunization
|
Kaic, Bernard
|
|
2001
|
19 |
27 |
p. 3615-3619
5 p.
|
artikel
|
| 14 |
Impact of osmolality on burning sensations during and immediately after intramuscular injection of 0.5 ml of vaccine suspensions in healthy adults
|
Nony, P
|
|
2001
|
19 |
27 |
p. 3645-3651
7 p.
|
artikel
|
| 15 |
Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus
|
Langeveld, Jan P.M
|
|
2001
|
19 |
27 |
p. 3661-3670
10 p.
|
artikel
|
| 16 |
Intranasal immunogenicity of a Δcya Δcrp-pabA mutant of Salmonella enterica serotype Typhimurium for the horse
|
Sheoran, Abhineet S
|
|
2001
|
19 |
27 |
p. 3787-3795
9 p.
|
artikel
|
| 17 |
MMR and autism: further evidence against a causal association
|
Farrington, C.Paddy
|
|
2001
|
19 |
27 |
p. 3632-3635
4 p.
|
artikel
|
| 18 |
Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants
|
McCluskie, Michael J
|
|
2001
|
19 |
27 |
p. 3759-3768
10 p.
|
artikel
|
| 19 |
MVA: a cuckoo in the vaccine nest?
|
Stittelaar, Koert J.
|
|
2001
|
19 |
27 |
p. v-vi
nvt p.
|
artikel
|
| 20 |
Plasmid DNA–recombinant Opc protein complexes for nasal DNA immunization
|
Musacchio, Alexis
|
|
2001
|
19 |
27 |
p. 3692-3699
8 p.
|
artikel
|
| 21 |
Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens
|
van der Burg, S.H.
|
|
2001
|
19 |
27 |
p. 3652-3660
9 p.
|
artikel
|
| 22 |
Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene
|
Okuda, Kenji
|
|
2001
|
19 |
27 |
p. 3681-3691
11 p.
|
artikel
|
| 23 |
Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques
|
Stittelaar, Koert J.
|
|
2001
|
19 |
27 |
p. 3700-3709
10 p.
|
artikel
|
| 24 |
Vaccination of pigs with a recombinant porcine adenovirus expressing the gD gene from pseudorabies virus
|
Hammond, Jef M
|
|
2001
|
19 |
27 |
p. 3752-3758
7 p.
|
artikel
|
| 25 |
Vaccines, CJD including variant CJD
|
Arya, Subhash C
|
|
2001
|
19 |
27 |
p. 3607-
1 p.
|
artikel
|
| 26 |
Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization
|
Reyes, Luane
|
|
2001
|
19 |
27 |
p. 3778-3786
9 p.
|
artikel
|
Tijdschrift beschrijving